Matt Kaeberlein

Active 1999–2026

141
Papers
30,070
Citations
81
h-index
134
i10-index

Citations

Citations per year for Matt Kaeberlein1988: 1 citations1998: 2 citations1999: 5 citations2000: 53 citations2001: 72 citations2002: 112 citations2003: 129 citations2004: 139 citations2005: 196 citations2006: 213 citations2007: 274 citations2008: 338 citations2009: 370 citations2010: 449 citations2011: 428 citations2012: 389 citations2013: 526 citations2014: 427 citations2015: 423 citations2016: 443 citations2017: 337 citations2018: 305 citations2019: 902 citations2020: 951 citations2021: 929 citations2022: 775 citations2023: 597 citations2024: 1,042 citations2025: 507 citations2026: 15 citations1989–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,587 citing papers, 32.8% of this breakdownChina: 1,237 citing papers, 11.3% of this breakdownUnited Kingdom: 638 citing papers, 5.8% of this breakdownGermany: 550 citing papers, 5% of this breakdownItaly: 342 citing papers, 3.1% of this breakdownSpain: 339 citing papers, 3.1% of this breakdownJapan: 323 citing papers, 3% of this breakdownCanada: 309 citing papers, 2.8% of this breakdownFrance: 290 citing papers, 2.7% of this breakdownSwitzerland: 276 citing papers, 2.5% of this breakdownAustralia: 214 citing papers, 2% of this breakdownSouth Korea: 205 citing papers, 1.9% of this breakdown
0%32.8%Other 24%

Fields

  • Biochemistry, Genetics and Molecular Biology53.4%
  • Medicine37.1%
  • Neuroscience3.2%
  • Agricultural and Biological Sciences1.4%
  • Immunology and Microbiology1.4%
  • Environmental Science0.7%
  • Other2.8%

Topics

  • Genetics, Aging, and Longevity in Model Organisms9%
  • Sirtuins and Resveratrol in Medicine7.6%
  • Autophagy in Disease and Therapy4.1%
  • Adipose Tissue and Metabolism3.9%
  • Mitochondrial Function and Pathology3.4%
  • Epigenetics and DNA Methylation2.3%
  • Other69.7%

Coauthors

All papers

Open in search
  1. Biomarkers of aging for the identification and evaluation of longevity interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2023 cited by 661

  2. Taurine deficiency as a driver of aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Costerwell Khyriem, Amanpreet Singh Chawla, Ankur Sharma, Nazan Sarper, Naibedya Chattopadhyay, B.K. Biswal, Carmine Settembre, Perumal Nagarajan, Kimara L. Targoff, Martin Picard, Sarika Gupta, Vidya Velagapudi, Anthony T. Papenfuss, Alaattin Kaya, Miguel Godinho Ferreira, Brian K. Kennedy, Julie K. Andersen, Gordon J. Lithgow, Abdullah Mahmood Ali, Arnab Mukhopadhyay, Aarno Palotie, Gabi Kastenmüller, Matt Kaeberlein, Henning Wackerhage, Bhupinder Pal, Vijay K. Yadav - Science 2023 cited by 409

  3. mTOR is a key modulator of ageing and age-related disease

    Authors: , , - Nature 2013 cited by 1,713

  4. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

    Authors: , , , - Nature 2000 cited by 3,509

  5. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

    Authors: , , , , , , , , , , , , , , , , , , - eLife 2016 cited by 478

  6. Healthy aging: The ultimate preventative medicine

    Authors: , , - Science 2015 cited by 328

  7. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

    Authors: , , - Genes & Development 1999 cited by 2,263

  8. mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome

    Authors: , , , , , , , , , , , , , , , , , - Science 2013 cited by 548

  9. Challenges in developing Geroscience trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mehmood Khan, Stephen B. Kritchevsky, Aksana Labokha, Olivier Lairez, Stephanie Lederman, Jean Mariani, Lefkos Middleton, John Newman, Angelo Parini, Susan Peschin, Marco Prunotto, Sami Sagol, Suzanne M. Tomlinson, Georg C. Terstappen, Jacques Touchon, Cendrine Tourette, Rob van Maanen, Eric Verdin, Stan Watowich, Lei Zhang, Alex Zhavoronkov - Nature Communications 2023 cited by 79

  10. Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients

    Authors: , , , , , , , , , - Science 2005 cited by 1,316

  11. ExplaiNAble BioLogical Age (ENABL Age): an artificial intelligence framework for interpretable biological age

    Authors: , , , - The Lancet Healthy Longevity 2023 cited by 73

  12. Histone H4 lysine 16 acetylation regulates cellular lifespan

    Authors: , , , , , , , , - Nature 2009 cited by 678

  13. Dietary restriction and lifespan: Lessons from invertebrate models

    Authors: , , - Ageing Research Reviews 2016 cited by 356

  14. Antiaging diets: Separating fact from fiction

    Authors: , , , - Science 2021 cited by 144

  15. Extension of chronological life span in yeast by decreased TOR pathway signaling

    Authors: , , , , - Genes & Development 2006 cited by 985

  16. Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C–Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2012 cited by 356

  17. How healthy is the healthspan concept?

    Authors: - GeroScience 2018 cited by 185

  18. Optogenetic rejuvenation of mitochondrial membrane potential extends C. elegans lifespan

    Authors: , , , , , , , - Nature Aging 2022 cited by 77

  19. Rapamycin and Alzheimer’s disease: Time for a clinical trial?

    Authors: , - Science Translational Medicine 2019 cited by 176

  20. Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David E. Harrison - Aging Cell 2022 cited by 68

  21. Replicative and Chronological Aging in Saccharomyces cerevisiae

    Authors: , , , - Cell Metabolism 2012 cited by 615

  22. Evaluation of off-label rapamycin use to promote healthspan in 333 adults

    Authors: , , , , , , , , , , , , - GeroScience 2023 cited by 61

  23. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs

    Authors: , , , , , , - GeroScience 2017 cited by 172

  24. An open science study of ageing in companion dogs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noah Snyder‐Mackler, William Thistlethwaite, Amanda K. Tinkle, M. Katherine Tolbert, Silvan R. Urfer, Benjamin S. Wilfond - Nature 2022 cited by 147